Literature DB >> 17475829

The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form.

Matteo G Levisetti1, Anish Suri, Shirley J Petzold, Emil R Unanue.   

Abstract

Several naturally occurring anti-insulin CD4 T cells were isolated from islet infiltrates of NOD mice. In accordance with the results of others, these T cells recognized the segment of the beta-chain from residues 9-23. Peptides encompassing the B:(9-23) sequence bound weakly to I-Ag7 in two main contiguous registers in which two residues at the carboxyl end, P20Gly and P21Glu, influenced binding and T cell reactivity. Naturally occurring insulin-reactive T cells exhibited differing reactivities with the carboxyl-terminal amino acids, although various single residue changes in either the flanks or the core segments affected T cell responses. The insulin peptides represent another example of a weak MHC-binding ligand that is highly immunogenic, giving rise to distinct populations of autoimmune T cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475829     DOI: 10.4049/jimmunol.178.10.6051

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  64 in total

1.  Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register.

Authors:  Brian D Stadinski; Li Zhang; Frances Crawford; Philippa Marrack; George S Eisenbarth; John W Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

Review 2.  Treg vaccination with a strong-agonistic insulin mimetope.

Authors:  Benno Weigmann; Carolin Daniel
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

3.  An update on the use of NOD mice to study autoimmune (Type 1) diabetes.

Authors:  Rodolfo José Chaparro; Teresa P Dilorenzo
Journal:  Expert Rev Clin Immunol       Date:  2010-11       Impact factor: 4.473

Review 4.  Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity?

Authors:  Anish Suri; Matteo G Levisetti; Emil R Unanue
Journal:  Curr Opin Immunol       Date:  2007-12-21       Impact factor: 7.486

5.  γδ T cells recognize the insulin B:9-23 peptide antigen when it is dimerized through thiol oxidation.

Authors:  M Kemal Aydintug; Li Zhang; Chao Wang; Dongchun Liang; J M Wands; Aaron W Michels; Brooke Hirsch; Brian J Day; Gongyi Zhang; Deming Sun; George S Eisenbarth; Rebecca L O'Brien; Willi K Born
Journal:  Mol Immunol       Date:  2014-05-20       Impact factor: 4.407

6.  Cutting edge: type 1 diabetes occurs despite robust anergy among endogenous insulin-specific CD4 T cells in NOD mice.

Authors:  Kristen E Pauken; Jonathan L Linehan; Justin A Spanier; Nathanael L Sahli; Lokesh A Kalekar; Bryce A Binstadt; James J Moon; Daniel L Mueller; Marc K Jenkins; Brian T Fife
Journal:  J Immunol       Date:  2013-10-11       Impact factor: 5.422

7.  Autoreactive T cells specific for insulin B:11-23 recognize a low-affinity peptide register in human subjects with autoimmune diabetes.

Authors:  Junbao Yang; I-Ting Chow; Tomasz Sosinowski; Nadia Torres-Chinn; Carla J Greenbaum; Eddie A James; John W Kappler; Howard W Davidson; William W Kwok
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

8.  Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes.

Authors:  Li Zhang; Frances Crawford; Liping Yu; Aaron Michels; Maki Nakayama; Howard W Davidson; John W Kappler; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

9.  Prediction of HLA-DQ8beta cell peptidome using a computational program and its relationship to autoreactive T cells.

Authors:  Kuan Y Chang; Emil R Unanue
Journal:  Int Immunol       Date:  2009-05-21       Impact factor: 4.823

10.  Functional inhibition related to structure of a highly potent insulin-specific CD8 T cell clone using altered peptide ligands.

Authors:  Liliana G Petrich de Marquesini; Antonis K Moustakas; Ian J Thomas; Li Wen; George K Papadopoulos; F Susan Wong
Journal:  Eur J Immunol       Date:  2008-01       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.